Treated AD mice possess higher levels of granulocyte colony-stimulating factor (G-CSF) that is a modulator of systemic immune responses by inhibiting pro-inflammatory cytokines and has been demonstrated to decrease Aβ deposition and to reverse cognitive impairment in an AD mice model [92]. This evidence concerns the gene CSF3 and Cognitive impairment.